Thalys Medical Technology Group Corporation (SHA:603716)

SHA:603716 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	166.98	209.44	278.59	394.54	473.55	661.75
Trading Asset Securities	-	-	-	-	12	-
Cash & Short-Term Investments	166.98	209.44	278.59	394.54	485.55	661.75
Cash Growth	-4.78%	-24.82%	-29.39%	-18.74%	-26.63%	29.73%
Accounts Receivable	931.2	1,361	1,608	1,832	1,830	1,571
Other Receivables	94.68	119.63	88.81	189.1	346.41	191.73
Receivables	1,026	1,481	1,697	2,021	2,177	1,763
Inventory	272.12	326.16	341.6	420.75	463.61	402
Prepaid Expenses	-	-	-	1	-	-
Other Current Assets	80.55	70.62	77.88	112.79	116.04	101.81
Total Current Assets	1,546	2,087	2,395	2,951	3,242	2,928
Property, Plant & Equipment	148.69	159.38	204.24	233.94	277.43	245.39
Long-Term Investments	283.44	284.96	277.44	333.04	267.13	266.02
Goodwill	43.7	43.7	115.8	142.41	155.02	154.64
Other Intangible Assets	31.39	33	34.3	29.82	31.32	32.16
Long-Term Accounts Receivable	-	-	43.12	49.74	61.86	69.21
Long-Term Deferred Tax Assets	151.62	152.62	197.21	126.13	82.49	50.16
Long-Term Deferred Charges	28.04	30.22	24.94	31.46	34.02	41.33
Other Long-Term Assets	38.94	39.06	50.03	61.71	142.27	119.24
Total Assets	2,271	2,830	3,342	3,959	4,294	3,906
Accounts Payable	317.79	730.75	747.1	737.56	583.76	440.26
Accrued Expenses	23.76	41.3	35.3	47.44	54.11	48.11
Short-Term Debt	310.28	422.76	443.7	778.87	690.25	694.75
Current Portion of Long-Term Debt	26.49	11.7	0.2	51.5	90	-
Current Portion of Leases	-	12.71	9.2	15.63	20.21	-
Current Income Taxes Payable	19.93	14.41	18.2	17.77	27.53	26.58
Current Unearned Revenue	22.47	35.39	23.35	26.85	65.67	32.8
Other Current Liabilities	79.52	102.43	118.42	160.81	204.99	145.69
Total Current Liabilities	800.25	1,371	1,395	1,836	1,737	1,388
Long-Term Debt	487.3	451.82	563.89	527.37	751.38	703.64
Long-Term Leases	26.55	25.86	32.87	31.74	47.48	-
Long-Term Unearned Revenue	0.04	0.05	0.07	0.14	0.15	0.24
Long-Term Deferred Tax Liabilities	8.61	10.82	13.29	17.4	5.88	5.1
Other Long-Term Liabilities	7.6	8.04	21.53	48.82	9.26	6.64
Total Liabilities	1,330	1,868	2,027	2,462	2,551	2,104
Common Stock	191.02	190.99	202.1	203.52	205.02	205.03
Additional Paid-In Capital	627.59	627.45	819.86	833.91	854.43	857.11
Retained Earnings	76.11	90.43	299.67	456.65	611.46	636.63
Treasury Stock	-24.03	-24.03	-175.67	-187.68	-200.55	-150.46
Comprehensive Income & Other	49.35	49.46	64.95	96.18	91.72	99.35
Total Common Equity	920.03	934.29	1,211	1,403	1,562	1,648
Minority Interest	20.97	27.75	103.78	94.33	180.83	154.9
Shareholders' Equity	940.99	962.04	1,315	1,497	1,743	1,803
Total Liabilities & Equity	2,271	2,830	3,342	3,959	4,294	3,906
Total Debt	850.63	924.84	1,050	1,405	1,599	1,398
Net Cash (Debt)	-683.65	-715.41	-771.26	-1,011	-1,114	-736.63
Net Cash Per Share	-3.36	-3.73	-3.99	-5.19	-5.62	-3.71
Filing Date Shares Outstanding	187.04	187.01	191.73	193.12	198.02	198.22
Total Common Shares Outstanding	187.04	187.01	191.73	193.12	198.02	198.22
Working Capital	745.29	715.68	999.26	1,114	1,506	1,540
Book Value Per Share	4.92	5.00	6.32	7.26	7.89	8.31
Tangible Book Value	844.93	857.59	1,061	1,230	1,376	1,461
Tangible Book Value Per Share	4.52	4.59	5.53	6.37	6.95	7.37
Buildings	-	18.68	18.68	18.56	18.56	18.56
Machinery	-	71.24	82.36	76.45	63.21	58.41
Construction In Progress	-	2.25	8.59	3.43	12.09	5.79

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.